Focal therapy using a novel cooled laser device for prostate cancer: early trial results

20260 citationsJournal Article

Authors

The PFLT-PC trial demonstrates that at 3 months, cLFT using the ProFocal device provides an 84% treatment success with low morbidity.

Published in: British Journal of Urology

Field-Weighted Citation Impact: 0.00